Compare
2 stocks, side by sideRelative performance · rebased to 100
ARGXRVMD
Pair ratio · ARGX ÷ RVMDRelative value, rich or cheap vs their own history
The price ratio ARGX ÷ RVMD with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| ARGXargenx SE | RVMDRevolution Medicines, Inc. | |
|---|---|---|
| Smart Score | 7/10 | 10/10 |
| Price | $888.65 | $178.17 |
| 1 month | +9.9% | +15% |
| 1 year | +56% | +345% |
| 5 year | +182% | +423% |
| P/E (TTM) | 37.1 | -27.6 |
| P/E vs sector | +18% | - |
| Market cap | $55.5B | $37.9B |
| Sector | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.